Table 2. Tests of Association for Cancer-Related Provisions.
| Cancer-related provision (No. with provision) | Value | P value |
|---|---|---|
| Cancer-related exclusion (n = 8) | ||
| Presence of NCI CCCa | χ2 = 4.51 | .03 |
| Disability rights statementa | χ2 = 0.99 | .32 |
| Oncologist or PC clinician on task forceb | NA | .19 |
| Cancer-related deprioritization (n = 17) | ||
| Presence of NCI CCCa | χ2 = 0.16 | .69 |
| Disability rights statementa | χ2 = 0.01 | .98 |
| Oncologist or PC clinician on task forceb | NA | .52 |
| Blood products (n = 17) | ||
| Presence of NCI CCCa | χ2 = 0.16 | .12 |
| Disability rights statementa | χ2 = 5.23 | .02 |
| Oncologist or PC clinician on task forceb | NA | .54 |
| Palliative care (n = 29) | ||
| Presence of NCI CCCb | NA | .47 |
| Disability rights statementb | NA | .66 |
| Oncologist or PC clinician on task forceb | NA | .73 |
Abbreviations: NA, not applicable; NCI CCC, National Cancer Institute Comprehensive Cancer Center; PC, palliative care.
a
χ2 test.
b
The Fisher exact test was used because of low observations per cell.